A Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems

This study is enrolling participants by invitation only.

Sponsored by:	Biomet Orthopedics, LLC
Information provided by:	Biomet, Inc.
ClinicalTrials.gov Identifier:	NCT00699270

Purpose

The purpose of this prospective clinical data collection is to document the performance and clinical outcomes of Biomet Humeral Stems

Condition
Osteoarthritis Avascular Necrosis Rheumatoid Arthritis Humeral Fractures

MedlinePlus related topics: Fractures Osteoarthritis Osteonecrosis Rheumatoid Arthritis

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	A Prospective, Non-Controlled, Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems

Further study details as provided by Biomet, Inc.:

Primary Outcome Measures:

UCLA End Result Score [ Time Frame: 3 months, 6 months, 1 year, 3 years, 5 years ] [ Designated as safety issue: No ]
X-rays [ Time Frame: 3 month, 1 year, 3 years, 5 years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Incidence of revisions and removals [ Time Frame: Any time ] [ Designated as safety issue: Yes ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	200
Study Start Date:	August 2007
Estimated Study Completion Date:	July 2015
Estimated Primary Completion Date:	July 2015 (Final data collection date for primary outcome measure)

Groups/Cohorts
Biomet Humeral Stems Biomet Humeral Stems: Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Patients that have already made the decision to undergo shoulder replacement surgery and will receive a Biomet humeral stem.

Criteria

Inclusion Criteria:

Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis
Rheumatoid Arthritis
Correction of functional deformity

Exclusion Criteria:

Absolute contraindications:

- Infection, Sepsis, and Osteomyelitis

Relative contraindications:

Uncooperative patient or patient with neurologic disorders who is incapable or unwilling to follow directions
Osteoporosis
Metabolic disorders which may impair bone function
Osteomalacia
Distant foci of infections which may spread to the implant site
Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00699270

Sponsors and Collaborators

Biomet Orthopedics, LLC

Investigators

Study Director:

Kenneth J Beres, MD

Clinical Research, Biomet Orthopedics, LLC

More Information

Responsible Party:	Biomet Orthopedics, LLC ( Kenneth Beres, MD Director Clinical Research )
Study ID Numbers:	Biomet 12380-76
Study First Received:	June 13, 2008
Last Updated:	July 3, 2008
ClinicalTrials.gov Identifier:	NCT00699270
Health Authority:	United States: Institutional Review Board

Keywords provided by Biomet, Inc.:

Total Shoulder Arthroplasty
Total Shoulder Replacement
Shoulder Arthritis

Study placed in the following topic categories:

Autoimmune Diseases
Osteonecrosis
Osteoarthritis
Joint Diseases
Fractures, Bone
Wounds and Injuries
Arthritis, Rheumatoid
Disorders of Environmental Origin

Humeral Fractures
Rheumatic Diseases
Bone Diseases
Arm Injuries
Necrosis
Musculoskeletal Diseases
Arthritis
Connective Tissue Diseases

Additional relevant MeSH terms:

Pathologic Processes
Immune System Diseases

ClinicalTrials.gov processed this record on January 16, 2009